A Comparative Assessment of Cocrystal and Amorphous Solid Dispersion Printlets Developed by Hot Melt Extrusion Paired Fused Deposition Modeling for Dissolution Enhancement and Stability of Ibuprofen

[1] Butreddy A(2022)Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: a review from bench to clinic Eur J Pharm Biopharm 177 289-307

[2] Schmied FP(2022)A novel aminomethacrylate-based copolymer for solubility enhancement—from radical polymer synthesis to manufacture and characterization of amorphous solid dispersions Polymers 14 1281-136

[3] Bernhardt A(2022)Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization Pharmaceutics 14 2203-2536

[4] Moers C(2022)Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation Int J Pharm 622 123-397

[5] Meier C(2022)Stable amorphous solid dispersion of flubendazole with high loading via electrospinning J Control Release 351 2505-26

[6] Endres T(2020)Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products Int J Pharm 586 381-25

[7] Klein S(2021)Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies Acta Pharm Sin B 11 1-103

[8] Tambe S(2022)Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone Pharm Res 39 690-27

[9] Jain D(2022)Continuous manufacturing and molecular modeling of pharmaceutical amorphous solid dispersions AAPS PharmSciTech 23 16-4103

[10] Meruva SK(2022)Solid dispersion formulations by FDM 3D printing—a review Pharmaceutics 14 95-189

[1] Butreddy A(2022)Hydroxypropyl methylcellulose acetate succinate as an exceptional polymer for amorphous solid dispersion formulations: a review from bench to clinic Eur J Pharm Biopharm 177 289-307

[2] Schmied FP(2022)A novel aminomethacrylate-based copolymer for solubility enhancement—from radical polymer synthesis to manufacture and characterization of amorphous solid dispersions Polymers 14 1281-136

[3] Bernhardt A(2022)Recent advances in amorphous solid dispersions: preformulation, formulation strategies, technological advancements and characterization Pharmaceutics 14 2203-2536

[4] Moers C(2022)Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation Int J Pharm 622 123-397

[5] Meier C(2022)Stable amorphous solid dispersion of flubendazole with high loading via electrospinning J Control Release 351 2505-26

[6] Endres T(2020)Amorphous solid dispersions: an update for preparation, characterization, mechanism on bioavailability, stability, regulatory considerations and marketed products Int J Pharm 586 381-25

[7] Klein S(2021)Pharmaceutical amorphous solid dispersion: a review of manufacturing strategies Acta Pharm Sin B 11 1-103

[8] Tambe S(2022)Role of surfactants on release performance of amorphous solid dispersions of ritonavir and copovidone Pharm Res 39 690-27

[9] Jain D(2022)Continuous manufacturing and molecular modeling of pharmaceutical amorphous solid dispersions AAPS PharmSciTech 23 16-4103

[10] Meruva SK(2022)Solid dispersion formulations by FDM 3D printing—a review Pharmaceutics 14 95-189